Placeholder Banner

Biotech Patenting and Tech Transfer at 2011 BIO International Convention

June 24, 2011

The Biotech Patenting and Tech Transfer track has a lot to offer 2011 BIO International Convention Attendees.  High level speakers include White House Intellectual Property Enforcement Coordinator Victoria Espinel, European Patent Office Director of Biotechnology Sjoerd Hoekstra, retired Chief Judge of the U.S. Court of Appeals for the Federal Circuit Paul Michel, and former Solicitors General Seth Waxman and Paul Clement to name a few.
I am particularly excited about the breadth of the session content.  Issues range from biosimilars, patentability of DNA, and recent Supreme Court decisions.  Those representing small biotechs and University Tech Transfer offices can enjoy sessions focused on collaborative R&D, technology transfer, and licensing.  Larger biotechs can learn about fighting counterfeiting abroad with the U.S. government and patenting issues in Europe and India.  Click on the links below to find out more about these Breakout Sessions: 

A Brave New World: Patent Litigation Tactics and Strategies for Biosimilars

Collaborative R&D From the Perspective of Large Multinationals, Universities and Start-ups  

Counterfeiting – How Corporations and the Government Can Work Together  

Drug Patent Linkage and Compulsory Licensing - Challenges of Working Patented Inventions in India for Pharma Sector 

European patent and unitary EU patent: the changes ahead  

Innovative Collaborations: Deal Structures for Nonprofit/For-Profit Collaborations  

Lessons From In-Licensing Partnership: Biotech Company Partners With Global Pharma to Deliver Cutting-Edge Follow-On Biologics  

Patents in the Supreme Court 

Technology Transfer: New Methods, New Media, New Models for Improving Interactions with Industry  

The Myriad Case and the Patentability of Isolated DNA Molecules